Vivanza Biosciences Ltd — Important, 04-05-2026: Company Update

VIVANZA BIOSCIENCES has rescheduled its board meeting for the consideration and approval of the audited financial results for the quarter and year ended March 31st, 2026. This meeting, previously scheduled, has been moved to a later date due to unavoidable circumstances. This indicates a slight delay in the release of earnings. The trading window for insiders will remain closed until 48 hours after these financial results are publicly announced, ensuring transparent market practices.